Europe - Frankfurt Stock Exchange - FRA:1SXP - DE000A3ENQ51 - Common Stock
The current stock price of 1SXP.DE is 18.93 EUR. In the past month the price decreased by -2.42%. In the past year, price decreased by -31.41%.
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| DIM.PA | SARTORIUS STEDIM BIOTECH | 47.1 | 19.76B | ||
| 56S1.DE | SARTORIUS STEDIM BIOTECH | 46.57 | 19.53B | ||
| SRT3.DE | SARTORIUS AG-VORZUG | 53.73 | 18.35B | ||
| SRT.DE | SARTORIUS AG | 41.89 | 14.30B | ||
| QIA.DE | QIAGEN N.V. | 20.22 | 8.99B | ||
| EVT.DE | EVOTEC SE | N/A | 2.07B | ||
| GXI.DE | GERRESHEIMER AG | 6.83 | 871.10M | ||
| FF.MI | FINE FOODS & PHARMACEUTICALS | 10.79 | 211.78M |
SCHOTT Pharma AG & Co. KgaA engages in the provision of designing drug containment and drug delivery solutions. The company is headquartered in Mainz, Hessen and currently employs 4,689 full-time employees. The company went IPO on 2023-09-28. The firm is primarily engaged in designing advanced drug containment solutions and drug delivery systems for the pharmaceutical and biotech industries. The Company’s portfolio ranges from syringes and cartridges to vials and ampoules, all made using Type I Borosilicate Glass and high-grade pharmaceutical polymer.
SCHOTT PHARMA AG& CO KGAA
Hattenbergstrasse 10
MAINZ HESSEN DE
Employees: 4689
Phone: 496131660
SCHOTT Pharma AG & Co. KgaA engages in the provision of designing drug containment and drug delivery solutions. The company is headquartered in Mainz, Hessen and currently employs 4,689 full-time employees. The company went IPO on 2023-09-28. The firm is primarily engaged in designing advanced drug containment solutions and drug delivery systems for the pharmaceutical and biotech industries. The Company’s portfolio ranges from syringes and cartridges to vials and ampoules, all made using Type I Borosilicate Glass and high-grade pharmaceutical polymer.
The current stock price of 1SXP.DE is 18.93 EUR. The price decreased by -0.37% in the last trading session.
SCHOTT PHARMA AG& CO KGAA (1SXP.DE) has a dividend yield of 0.87%. The yearly dividend amount is currently 0.15.
1SXP.DE has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 6 out of 10.
19 analysts have analysed 1SXP.DE and the average price target is 29.58 EUR. This implies a price increase of 56.26% is expected in the next year compared to the current price of 18.93.
SCHOTT PHARMA AG& CO KGAA (1SXP.DE) will report earnings on 2025-12-11.
ChartMill assigns a fundamental rating of 6 / 10 to 1SXP.DE. 1SXP.DE scores excellent on profitability, but there are some minor concerns on its financial health.
Over the last trailing twelve months 1SXP.DE reported a non-GAAP Earnings per Share(EPS) of 0.97. The EPS decreased by -3% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 15.07% | ||
| ROA | 9.62% | ||
| ROE | 17.03% | ||
| Debt/Equity | 0.09 |
19 analysts have analysed 1SXP.DE and the average price target is 29.58 EUR. This implies a price increase of 56.26% is expected in the next year compared to the current price of 18.93.
For the next year, analysts expect an EPS growth of 3.25% and a revenue growth 2.31% for 1SXP.DE